Khanban, H.; Fattahi, E.; Talkhabi, M. In Vivo Administration of G9a Inhibitor A366 Decreases Osteogenic Potential of Bone Marrow-Derived Mesenchymal Stem Cells. EXCLI J. 2019, 18, 300-309.